SCALP MICROPIGMENTATION FOR WOMEN
Hair loss presents unique challenges for women. We provide scalp micropigmentation options specially tailored for female clients who want to do something to address the problem. There are many reasons why a women experience hair loss. Common causes are hormonal imbalances, postpartum hair loss following childbirth, Alopecia-derived conditions such as Telogen Effluvium or Alopecia Areata or drug-induced thinning, for example during chemotherapy or other medical treatment.
Whilst losing hair is never an easy experience, the effects on female clients can be particularly devastating. We understand this, and our team is extremely sensitive to the needs of our clients. There are many treatment options available, so a consultation is always the first step towards finding a suitable long term solution that provides the best possible result.
SMP tailored for women
The best approach for each client depends on their individual needs. Most importantly, we need to understand what is causing your hair to be lost in the first place, and how your condition is likely to change over time. With this knowledge, we are able to create a tailored treatment plan that exactly matches your requirements, not only now but long into the future.
In most cases, our female clients wish to keep their hair at its current length. This is usually possible with correct treatment planning, as the scalp micropigmentation process is highly adaptable to address a wide range of situations. This is especially true when diffused (generalised) thinning is taking place across the entire head, but is also possible when addressing conditions such as Alopecia Areata, depending on where the hair is being lost, and the hairstyle worn. For those who have experienced substantial or even total hair loss, we are able to replicate a short cropped style that appears like a choice, rather than a condition. This option has restored the confidence of many hundreds of women who are struggling to come to terms with hair loss, particularly after chemotherapy.